Not Tagged
Not Tagged
['car-t']
3/3: "it's also a very exciting time in that these approved therapies are just the first iterations of what car-t can do in #multiplemmyeloma." #asco2022 
Personalized #CancerTreatment + leading-edge #CancerResearch and #ClinicalTrials = unparalleled #CancerCare. https://t.co/geLhFEZv7T